Endocardial radiofrequency ablation of septal hypertrophy in the interventional treatment of the hypertrophic obstructive cardiomyopathy; comparison with the alcohol septal ablation, pilot data of the randomized trial
Cor et Vasa · 06.11.2025 · 67 (5) · 561-570
DOI: 10.33678/cor.2025.101 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Cor et Vasa, erschienen am 06.11.2025. Verfasst von Katarína Doležalová und 6 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Doležalová, K., Stárek, Z., Pešl, M., Souček, F., Sitar, J., Honěk, T., & Krejčí, J. (2025). Endocardial radiofrequency ablation of septal hypertrophy in the interventional treatment of the hypertrophic obstructive cardiomyopathy; comparison with the alcohol septal ablation, pilot data of the randomized trial. Cor et Vasa, 67(5), 561-570. https://doi.org/10.33678/cor.2025.101
Vancouver
Doležalová K, Stárek Z, Pešl M, Souček F, Sitar J, Honěk T, et al. Endocardial radiofrequency ablation of septal hypertrophy in the interventional treatment of the hypertrophic obstructive cardiomyopathy; comparison with the alcohol septal ablation, pilot data of the randomized trial. Cor et Vasa. 2025;67(5):561-570. doi:10.33678/cor.2025.101
BibTeX
@article{Dolealov2025,
author = {Doležalová, Katarína and Stárek, Zdeněk and Pešl, Martin and Souček, Filip and Sitar, Jan and Honěk, Tomáš and Krejčí, Jan},
title = {Endocardial radiofrequency ablation of septal hypertrophy in the interventional treatment of the hypertrophic obstructive cardiomyopathy; comparison with the alcohol septal ablation, pilot data of the randomized trial},
journal = {Cor et Vasa},
year = {2025},
volume = {67},
number = {5},
pages = {561--570},
doi = {10.33678/cor.2025.101}
}
EUVIMED